Live feed
Filing
SC 13G
SC 13G0001104659-16-159051·Armata Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
AmpliPhi Biosciences Corp
Security class unavailable · CUSIP: 3211P2020
Event date: 2016-11-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,133,334
- Percent of class
- 6.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-159051
- Form type
- SC 13G
- Filer
- Armata Pharmaceuticals, Inc.
- CIK
- CIK 921114
- Filed
- Nov 25, 2016
- Reporting period
- Nov 17, 2016
- Description
- Schedule 13G beneficial ownership